ArticleImmunity, inflammation and disease2022

Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time-series analysis.

Yao-Fan Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.